Is Glycine Sleep Quality Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Glycine Sleep Quality Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Data synthesis and subgroup analysis were performed via SMD, WMD, relative risk (RR), and 95% CI to evaluate the effects of rTMS and its influencing factors. [Cao Z (2026); evidence level 1] - The rTMS group demonstrated markedly improved sleep quality compared with sham rTMS recipients in individuals with insomnia disorder. [Cao Z (2026); evidence level 1] - Conclusion Independent rTMS and rTMS-medication combinations significantly improve sleep patterns and rest quality in patients with Insomnia Disorder. [Cao Z (2026); evidence level 1] - First-line treatments are limited by accessibility or side effects, necessitating alternative approaches. [Cao Z (2026); evidence level 1] - Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. [Conti F (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.